Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

CERN MDSO WBMD QSII Macroaxis 15 Office Supplies RUB Bitcoins Apparel 
Benchmark SP 500  1,629   22.88  Index Moved Down -1.39% United States ...


Processing
Collecting data for MDAS

MedAssets quote and profile

 
 Companies |  Insiders  | Dashboard  
     
18.03
  
STOCK
(0.11)  Macroaxis: -0.61 Down   0.61%  
Year To Date
10.7319.99
Last 1 Month(s)
16.418.14
Trading Day 
17.9618.3
June 20 2013 

Diversification Suggestion

Use MedAssets to protect against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier
Analyze MedAssets Inc Trend or Check current 30 days MedAssets correlation with market (S&P 500)
1 Month Beta 1.17  
Highest Price:  
Lowest Price:  
18.14  
16.4  
June 18 2013 
May 31 2013 
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, MedAssets will likely underperform.
MedAssets Inc Large BetaMedAssets Inc Beta Legend
MDAS United States Nasdaq
MedAssets Inc
Technology
Healthcare Information Services
Benchmark S&P 500
http://www.medassets.com
Contact Number: 678. 323. 2500
Currency: USD - US Dollar
Traded on NASDAQ
    
Current Valuation2 B
Shares Outstanding60.92 M
Number of Shares Shorted1.34 M
Revenue663.07 M
 thisRed MDAS MDAS agains markets  0.61 % Macroaxis: 0.61 Moved Down  
 
 United States Russel   1.35 % Macroaxis: change 1.35 Moved Down  
 
 United States SP 500   1.39 % Macroaxis: change 1.39 Moved Down  
 
 United States NYSE   1.53 % Macroaxis: change 1.53 Moved Down  
 
Compare to Competition Alpha & Beta   Get Advice

MedAssets Leadership

John Bardis Founder, Chairman, CEO and Pres
Terrence Mulligan Independent Vice Chairman of the Board
Bruce Wesson Independent Vice Chairman of the Board, MBA
Lance Culbreth Senior Vice President Chief Accounting Officer

MedAssets Price and Market Media

The median price of MedAssets for the period between Tue, May 21, 2013 and Thu, Jun 20, 2013 is 17.36 with a coefficient of variation of 2.95. The daily time series for the period is distributed with a sample standard deviation of 0.51, arithmetic mean of 17.27, and mean deviation of 0.4. The Stock received substential amount of media coverage during this period.
MedAssets         SP 500
Price Growth (%)
 
Change Benchmark  Embed  Export  Timeline
1
MEDASSETS INC. Bon Secours Health System Renews Relationship...05/24/2013Macroaxis: News
2
Should You Avoid Allscripts Healthcare Solutions Inc05/29/2013Macroaxis: News
3
MedAssets Receives New Coverage from Analysts at B. Riley06/05/2013Macroaxis: News
4
MedAssets Wins Champion for Change Award06/11/2013Businesswire News
5
MedAssets Coverage Initiated at Sterne Agee06/13/2013Macroaxis: News
6
MEDASSETS INC. MedAssets Introduces ProcuretoPay Solutions t...06/18/2013Macroaxis: News

MedAssets Summary

MedAssets Inc [MDAS] is traded on NASDAQ in USA. It is located in MedAssets, Inc.Alpharetta, GA and employs 3,100 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.05 B. MedAssets Inc conducts business under Technology sector and is part of Healthcare Information Services industry. This company has 60.92 M outstanding shares of which 1.34 M shares are now shorted by private and institutional investors with about 5.2 trading days to cover.
MedAssets, Inc., a financial and performance improvement company, offer technologyenabled solutions and services for hospitals, health systems, and other ancillary healthcare providers in the United States. more
Past Market
Over 30
Days
2
Out Of
100
 
Chance of
Less
Than
47 %
 
Follow MedAssets with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add MedAssets to your reader
 

MedAssets Research Report

MedAssets vs. Cerner

Correlation analysis and fundamentals comparison between MedAssets Inc and Cerner

MedAssets Executives

Charles Garner CFO and Executive VP, CFA
Michael Nolte COO and Executive VP, MBA

MedAssets Directors

John Rutherford Independent Director, MBA
C Piccolo Independent Director
Rand Ballard Chief Customer Officer, Sr. Executive VP and Director
Carol Zierhoffer Director
Harris Hyman Independent Director, MBA

MedAssets Fundamentals

Price to Book vs Revenue
Earnings Per Share vs EBITDA
Price to Book vs Shares Owned by Institutions
Cash Flow from Operations vs EBITDA

MedAssets vs Competition

MedAssets vs. Cerner Corporation
MedAssets vs. Medidata Solutions Inc
MedAssets vs. Quality Systems Inc
MedAssets vs. Computer Programs Systems Inc
MedAssets vs. Merge Healthcare Incorporated

MedAssets June 20 2013 Opportunity Range

Downside Deviation1.74
Information Ratio0.07
Maximum Drawdown5.38
Value At Risk(2.97)
Potential Upside2.47

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium